Observation-GenomicTherapeuticImplication-Example

Example of an Observation representing a Therapeutic Implication derived from Genomic Testing.

Observation
{
"resourceType": "Observation",
"id": "Observation-GenomicTherapeuticImplication-Example",
"meta": {
"profile": [
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/therapeutic-implication",
"http://hl7.eu/fhir/laboratory/StructureDefinition/Observation-resultslab-eu-lab"
]
},
"status": "final",
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/observation-category",
"code": "laboratory"
}
]
},
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0074",
"code": "GE"
}
]
}
],
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code": "therapeutic-implication"
}
]
},
"subject": {
"reference": "Patient/Patient-PheobeSmitham-Example"
},
"effectiveDateTime": "2023-09-16",
{
"system": "https://fhir.nhs.uk/Id/ods-organization-code",
"value": "R0A"
}
}
],
{
"reference": "Observation/Observation-GenomicsVariantSLC52A2-Example"
}
],
{
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code": "therapeutic-implication",
"display": "Therapeutic Implication"
}
]
},
"coding": [
{
"system": "http://loinc.org",
"code": "LA9661-5",
"display": "Presumed responsive"
}
]
}
},
{
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "51963-7",
"display": "Medication assessed"
}
]
},
"coding": [
{
"system": "http://snomed.info/sct",
"code": "438481000124108",
"display": "Riboflavin supplement"
}
]
}
}
],
"note": [
{
"text": "High dose riboflavin supplementation has been reported to ameliorate the progression of this disorder (Foley et al 2014 PMID22740598)"
}
]
}
<Observation xmlns="http://hl7.org/fhir">
<id value="Observation-GenomicTherapeuticImplication-Example" />
<profile value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/therapeutic-implication" />
<profile value="http://hl7.eu/fhir/laboratory/StructureDefinition/Observation-resultslab-eu-lab" />
</meta>
<status value="final" />
<system value="http://terminology.hl7.org/CodeSystem/observation-category" />
<code value="laboratory" />
</coding>
</category>
<system value="http://terminology.hl7.org/CodeSystem/v2-0074" />
<code value="GE" />
</coding>
</category>
<system value="http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs" />
<code value="therapeutic-implication" />
</coding>
</code>
<reference value="Patient/Patient-PheobeSmitham-Example" />
</subject>
<effectiveDateTime value="2023-09-16" />
<system value="https://fhir.nhs.uk/Id/ods-organization-code" />
<value value="R0A" />
</identifier>
</performer>
<text value="High dose riboflavin supplementation has been reported to ameliorate the progression of this disorder (Foley et al 2014 PMID22740598)" />
</note>
<reference value="Observation/Observation-GenomicsVariantSLC52A2-Example" />
</derivedFrom>
<system value="http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs" />
<code value="therapeutic-implication" />
<display value="Therapeutic Implication" />
</coding>
</code>
<system value="http://loinc.org" />
<code value="LA9661-5" />
<display value="Presumed responsive" />
</coding>
</valueCodeableConcept>
</component>
<system value="http://loinc.org" />
<code value="51963-7" />
<display value="Medication assessed" />
</coding>
</code>
<system value="http://snomed.info/sct" />
<code value="438481000124108" />
<display value="Riboflavin supplement" />
</coding>
</valueCodeableConcept>
</component>
</Observation>